Valeant Pharmaceuticals International Inc. making a bid to buy out another company is news, but not of the “man bites dog” or even “Butler reaches the Final Four two years in a row” category. But when three big pharma companies get together to swap vaccine, oncology and animal health units, that catches extra notice.
None of that, however, overshadowed the revelation that Pfizer Inc
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?